Veralto Co. (NYSE:VLTO) Shares Purchased by Verition Fund Management LLC

Verition Fund Management LLC boosted its stake in shares of Veralto Co. (NYSE:VLTO - Free Report) by 105.5% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 93,595 shares of the company's stock after purchasing an additional 48,047 shares during the period. Verition Fund Management LLC's holdings in Veralto were worth $10,470,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Tidal Investments LLC increased its holdings in shares of Veralto by 40.8% during the 1st quarter. Tidal Investments LLC now owns 14,855 shares of the company's stock valued at $1,317,000 after purchasing an additional 4,303 shares in the last quarter. Cetera Investment Advisers increased its holdings in Veralto by 247.8% in the first quarter. Cetera Investment Advisers now owns 48,428 shares of the company's stock valued at $4,294,000 after buying an additional 34,505 shares in the last quarter. Cetera Advisors LLC raised its position in shares of Veralto by 90.2% in the first quarter. Cetera Advisors LLC now owns 11,624 shares of the company's stock worth $1,031,000 after acquiring an additional 5,511 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Veralto by 357.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 810 shares of the company's stock worth $76,000 after acquiring an additional 633 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Veralto by 79.7% during the 2nd quarter. GAMMA Investing LLC now owns 3,133 shares of the company's stock valued at $299,000 after acquiring an additional 1,390 shares during the period. Hedge funds and other institutional investors own 91.28% of the company's stock.

Insider Activity

In related news, SVP Surekha Trivedi sold 753 shares of the business's stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $112.55, for a total transaction of $84,750.15. Following the completion of the transaction, the senior vice president now directly owns 11,165 shares of the company's stock, valued at $1,256,620.75. The trade was a 6.32 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jennifer Honeycutt sold 13,190 shares of Veralto stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $110.15, for a total value of $1,452,878.50. Following the completion of the transaction, the chief executive officer now owns 138,546 shares of the company's stock, valued at $15,260,841.90. The trade was a 8.69 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,448 shares of company stock valued at $1,698,675. 0.31% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Royal Bank of Canada upped their target price on Veralto from $108.00 to $111.00 and gave the stock a "sector perform" rating in a research note on Friday, October 25th. BMO Capital Markets increased their price objective on shares of Veralto from $117.00 to $119.00 and gave the company an "outperform" rating in a report on Monday, September 30th. UBS Group assumed coverage on shares of Veralto in a research report on Tuesday, August 13th. They issued a "neutral" rating and a $118.00 target price on the stock. Finally, Stifel Nicolaus upped their price target on shares of Veralto from $117.00 to $119.00 and gave the stock a "buy" rating in a research report on Wednesday, October 16th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $108.27.

Veralto Trading Up 0.2 %

Shares of Veralto stock traded up $0.22 during trading hours on Friday, hitting $108.19. The company's stock had a trading volume of 586,303 shares, compared to its average volume of 1,324,704. The firm has a fifty day moving average of $108.00 and a 200-day moving average of $104.90. The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.87 and a current ratio of 2.13. The stock has a market cap of $26.76 billion and a price-to-earnings ratio of 33.39. Veralto Co. has a twelve month low of $73.91 and a twelve month high of $115.00.

Veralto (NYSE:VLTO - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The company reported $0.89 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.85 by $0.04. Veralto had a net margin of 15.69% and a return on equity of 52.85%. The business had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.30 billion. During the same period in the previous year, the firm earned $0.75 EPS. The business's revenue was up 4.7% on a year-over-year basis. Research analysts forecast that Veralto Co. will post 3.48 EPS for the current year.

Veralto Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Friday, September 27th were given a dividend of $0.09 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.36 annualized dividend and a dividend yield of 0.33%. Veralto's dividend payout ratio is presently 11.11%.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.